Assessment and Management of Pain at the End of Life _ ___________________________________________
F inal E xam
ASSESSMENT AND MANAGEMENT OF PAIN AT THE END OF LIFE
Select the best answer for each question and mark your answers on the Final Examination Answer Sheet found on page 67, or complete your test online at BOOK.CME.EDU. A passing grade of at least 70% must be achieved in order to receive credit for this course.
1. The reported prevalence of pain at the end of life is greatest among adults with
6. The maximum recommended dose of acetaminophen is A) 1–1.5 g per day.
A) cancer. B) COPD. C) diabetes. D) heart failure.
B) 3–4 g per day. C) 5–7 g per day. D) 8–10 g per day.
2. Which of the following is the most reliable indicator of pain? A) Patients’ self-report
7. The onset of action of fentanyl transdermal patch is
A) 5 to 10 minutes. B) 30 to 60 minutes. C) 8 to 12 hours. D) 12 to 18 hours.
B) Results of physical examination C) Results of functional assessment D) Results of multidimensional assessment
3. Research has shown that pain is A) overestimated by patients.
8. According to the WHO ladder, which of the following is the opioid considered to be the first-line treatment for Step 3 pain management?
B) overestimated by healthcare professionals. C) underestimated by healthcare professionals. D) underestimated by patients’ family members.
A) Fentanyl B) Morphine C) Methadone D) Oxycodone
4. Generalized pain is usually indicative of A) tissue lesions. B) underlying tissue injury. C) central nervous system damage. D) All of the above
9. What is the most common side effect of opioid use?
A) Allergy B) Nausea C) Sedation D) Constipation
5. According to the World Health Organization (WHO) ladder, pain should be managed A) with only nonopioids for steps 1 and 2. B) in a stepwise progression from step 1 to step 3. C) in a manner according to the severity of the pain. D) with opioids given around the clock and nonopioids given on an as-needed basis.
10. Which of the following is NOT a barrier to the use of palliative radiotherapy?
A) Transportation issues B) Patient inconvenience C) Longer life expectancy D) Lack of knowledge in the primary care community
Course Code: MDNJ02EL
12
MDNJ1525
Powered by FlippingBook